Supreme Patent Ruling | Chemical & Engineering News
Volume 85 Issue 25 | p. 6 | Letters
Issue Date: June 18, 2007

Supreme Patent Ruling

Department: Letters

The Supreme Court's ruling is rather ridiculous (C&EN, May 7, page 13). Because of the complexity of some racemates, resolving them into the component steroisomers is no easy task. Any company that succeeds in this process deserves a patent; not just a process patent but a patent on the active isomer. That presumes that the other isomer will not be found "effective" for some other use and approved by the Food & Drug Administration, actually doing more harm than good.

Art Goldkamp
Redmond, Wash.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment